HOME >> BIOLOGY >> NEWS
Predicting PET imaging's future: Diagnosing and treating diseases ASAP

RESTON, Va. -- Imagine a new world of detecting and diagnosing diseases sooner--even before any symptoms are present. Consider the possibility of receiving individualized, targeted molecular, cellular or genetic medical treatment as soon as possible and of undergoing scanning that can quickly tell your doctor whether your treatment is working. Continued advances in positron emission tomography (PET) imaging are key to this future, according to Simon R. Cherry, professor of biomedical engineering at the University of California, Davis.

"Earlier detection of diseases and of the effect of treatment on them is the main impetus in advancing PET technology," says Cherry, who offered predictions about PET's growing importance in the November issue of the Journal of Nuclear Medicine. In the far future, individuals may be able to take a simple--as yet undeveloped--annual blood and/or urine test to screen protein or metabolite levels that could indicate common diseases, said the author of "The 2006 Henry N. Wagner Lecture: Of Mice and Men (and Positrons)--Advances in PET Imaging Technology." Since nearly all diseases alter the body's biochemical processes, "this type of test could allow a doctor to compare a patient's results with those from previous years and flag a beginning disease process," added the director of the UC Davis Center for Molecular and Genomic Imaging. "Once a change is noted, it will be critical to localize and visualize the disease and monitor how it responds to therapy. This is where PET technology offers powerful opportunities," he said. With PET's molecular imaging ability--the ability to "photograph" biological targets or pathways--doctors will be able to detect molecular changes that could provide valuable information about treating and even preventing the onset of Alzheimer's or other brain disorders, cancers and heart disease. "PET's diagnostic ability in the future will tell us something about the precise molecular makeup of disease in
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
1-Nov-2006


Page: 1 2 3

Related biology news :

1. Every moment counts: Predicting treatment responses earlier for brain tumor patients
2. Predicting catastrophic transitions
3. Predicting species abundance in the face of habitat loss
4. Predicting success
5. Predicting chemotherapy outcome
6. Predicting the future: Mirror neurons reflect the intentions of others
7. Predicting infection risk of mosquito-borne disease
8. Examining molecular imagings hot future
9. Back to the future: Mastodon extends the time limit on DNA sequencing
10. Nanotechnologys past, present and future: A Congressional perspective
11. Biorenewables products for a sustainable future: York leads new consortium

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... , ... August 19, 2020 , ... ... LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty ... recently published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research ...
(Date:8/21/2020)... ... August 20, 2020 , ... ... Hassan Movahhed , a Clinical Operations executive with expertise in clinical trial planning ... the firm as an Expert Consultant. Throughout his career, Mr. Movahhed has helped ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced ... for public health agencies of all sizes. With a focus on tracking symptoms ... find appropriate health care, Mosio helps public health departments automate communications and provide ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine today revealed ... prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique ... independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:8/7/2020)... ... 06, 2020 , ... VGXI, a highly regarded CDMO supporting ... purchase of greenfield for a new, expanded manufacturing facility. The site is located ... the initial acquisition, with an option to purchase an additional 21 acres for ...
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its platform ... Biologics since its formation in 2016, the company is relaunching itself under the Ardent ... its base of innovative therapies for osteoarthritis and cancer. , ...
Breaking Biology Technology:
Cached News: